Scientific letter N°6

Dear readers,
We are glad to present you the new edition of our Scientific Letter, in which we are happy to share with you our Scientific Management Researches, as well as the latest evolutions of AtlanChim Pharma and Atlantic Bone Screen Companies.
For this New Year, the first important step is the obtaining of the ISO 9001 : 2008 Certificate of conformity (delivered by LRQA organization) for AtlanChim Pharma Company and the renewal of it for Atlantic Bone Screen Company. Giving a strong emphasis on the quality of our work, this accreditation guarantees you the respect of our commitments and most likely, your full satisfaction.
We also take this opportunity to announce to you the enlargement of AtlanChim Pharma Company team, through the arrival around mid-May of a new Project Leader with a specialization in Carbohydrates Chemistry. We also extend our production capacity and acquire new equipment.
In this first edition of the year, you will discover the new Scientific article written by Dr. André GUINGANT and entitled “Integrin alpha V beta 3 as a target for treatment of osteoporosis : design and synthesis of non peptide antagonists”.
The whole Atlanchim Pharma Company team wishes you a nice reading.

Ronan LE BOT
CEO